No clinically relevant difference in patient-reported outcomes between the direct superior approach and the posterolateral or anterior approach for primary total hip arthroplasty: analysis of 37,976 primary hip arthroplasties in the Dutch Arthroplasty Registry

• Published in: Acta orthopaedica Vol. 94; pp. 543 - 549
• Main Authors: Van Dooren, Bart, Peters, Rinne M, van Steenbergen, Liza N, Post, Richard A J, Ettema, Harmen B, Bolder, Stefan B T, Schreurs, B Willem, Zijlstra, Wierd P
• Format: Journal Article
• Language: English
• Published: Medical Journals Sweden, on behalf of the Nordic Orthopedic Federation 31-10-2023; Medical Journals Sweden
• ISSN: 1745-3674; 1745-3682
• DOI: 10.2340/17453674.2023.23729

Background and purpose: The direct superior approach (DSA) is a modification of the posterolateral approach (PLA) for total hip arthroplasty (THA). Patient-reported outcome measures (PROMs) of the DSA have not been investigated previously using nationwide data. Our aim was to assess PROMs after THA using the DSA compared with the PLA and, secondarily, with the anterior approach (DAA).Patients and methods: In this population-based cohort study we included 37,976 primary THAs performed between 2014 and 2020 (PLA: n = 22,616; DAA: n = 15,017; DSA: n = 343) using Dutch Arthroplasty Registry data. PROMs (NRS pain, EQ-5D, HOOS-PS, and OHS) were measured preoperatively, and at 3 and 12 months postoperatively. Repeated measurements were analyzed using mixed-effects models, adjusted for confounders, to investigate the association between surgical approach and PROMs over time.Results: From baseline to 3 and 12 months, improvements for NRS pain scores, EQ-5D, and OHS were comparable for the DSA compared with the PLA or DAA. No difference was found in HOOS-PS improvement 3 months postoperatively between DSA and PLA (–0.2, 95% confidence interval [CI] –2.4 to 1.9) and between DSA and DAA (–1.7, CI –3.9 to 0.5). At 12 months postoperatively, patients in the DSA group had improved –2.8 points (CI –4.9 to –0.6) more in HOOS-PS compared with the DAA, but not with the PLA group (–1.0, CI –3.2 to 1.1).Conclusion: Our study showed no clinically meaningful differences between the DSA and either PLA or DAA.